Market Overview:
The global heel incision devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of foot and ankle disorders, rising geriatric population, and technological advancements in heel incision devices. Based on type, the global heel incision devices market is segmented into micro-preemie, preemie, newborn, and infant segments. The preemie segment is expected to account for the largest share of the global heel incision devices market in 2018 owing to increasing incidence of premature births across the world. Based on application, hospitals are expected to account for the largest share of the global heel incision devices market in 2018 followed by specialty clinics and ambulatory surgical centers (ASCs).
Product Definition:
Heel incision devices are surgical instruments used to make an incision in the heel. They may be used to perform a variety of procedures, such as draining an abscess or removing a foreign body from the heel. Heel incision devices are important because they allow surgeons to access the heel easily and effectively.
Micro-preemie:
Micro preemie is a term used for infants born before the completion of 37 weeks of pregnancy. The normal full-term pregnancy lasts 40 weeks, and a baby that is born prematurely usually weighs around 1 pound (0.45 kg). At or below the limit of viability, as stated by the National Institute of Health (NIH), approximately 90% to 95% of babies born before 22 completed weeks gestation will die in utero or shortly after birth.
Preemie:
Preemie is a device used in the treatment of metatarsophalangeal joint dysfunction. It helps to realign the metatarsophalangeal joint and improve its function. The main objective of using preemie in surgery is to reduce pain after an operation by improving movement in patients with toe, foot or ankle problems.
Application Insights:
Based on application, the global market is segmented into hospitals, specialty clinics, ambulatory surgical centers (ASCs), and others. Hospitals held the largest revenue share in 2017 owing to increasing prevalence of chronic diseases such as diabetes and cardiac disorders that require surgeries for treatment. Moreover, an increase in number of childbirths has led to a significant rise in demand for heel surgery at hospitals worldwide. According to WHO¢â‚¬â„¢s 2015 Report Card on Life expectancy & Quality of Life, about 29% of deaths occur before reaching the age of 70 globally which contributes towards a large share held by hospitals within the overall industry.
The ASCs are anticipated to be one of fastest-growing segments over forecast period due largelyASC providers offering advanced services with cost-effective solutions cateringto rising healthcare needs across various regions worldwide thereby drivingthe growth further.
Regional Analysis:
North America dominated the global heel incision devices market in 2017. This can be attributed to increasing R&D investments by government and private entities, rising adoption of new technologies, high healthcare expenditure levels, and favorable reimbursement policies & regulatory reforms in this region. For instance, the Patient Protection and Affordable Care Act (PPACA) encourages innovation through coverage expansions for advanced medical products.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure coupled with growing awareness about early diagnosis of heel spur conditions among mothers during pregnancy. Availability of these surgeries at low cost in countries like India is also contributing towards regional growth. In addition, an increase in disposable income levels will boost demand further due to rise usage of high heels by women working professionally or attending social events etc.
Growth Factors:
- Increasing incidence of foot and ankle disorders: The global prevalence of foot and ankle disorders is increasing at a rapid pace. This is primarily attributed to the changing lifestyles and growing aging population. Heel incision devices are increasingly being used for the treatment of various foot and ankle disorders, thereby driving the growth of this market.
- Technological advancements: The development of novel heel incision devices that offer enhanced performance is propelling the growth of this market. For instance, in January 2017, Zimmer Biomet Holdings Inc., launched its new product – Zimmer Biomet Heelift – a minimally invasive device designed to address heel pain by providing an alternative to traditional open surgery techniques. Such technological advancements are expected to boost the demand for heel incision devices in the coming years.
- Rising awareness about benefits offered by heel incision devices: There is a growing awareness among healthcare professionals as well as patients about the benefits offered by heel incision devices such as reduced post-operative pain and faster recovery times when compared with traditional surgical procedures involving open cuts on heels or ankles.. This is likely to fuel demand for these devices in forthcoming years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Heel Incision Devices Market Research Report
By Type
Micro-preemie, Preemie, Newborn, Infant
By Application
Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others
By Companies
Owen Mumford Ltd., Cardinal Health, NSP Medicals, Torvan Medical Inc, Smiths Medical, Clinical Innovations, LLC, MediCore, Vitrex Medical A/S
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Heel Incision Devices Market Report Segments:
The global Heel Incision Devices market is segmented on the basis of:
Types
Micro-preemie, Preemie, Newborn, Infant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Owen Mumford Ltd.
- Cardinal Health
- NSP Medicals
- Torvan Medical Inc
- Smiths Medical
- Clinical Innovations
- LLC
- MediCore
- Vitrex Medical A/S
Highlights of The Heel Incision Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Micro-preemie
- Preemie
- Newborn
- Infant
- By Application:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heel Incision Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Heel Incision Devices are medical devices that are inserted into the heel to help relieve pain and pressure in the heel.
Some of the major players in the heel incision devices market are Owen Mumford Ltd., Cardinal Health, NSP Medicals, Torvan Medical Inc, Smiths Medical, Clinical Innovations, LLC, MediCore, Vitrex Medical A/S.
The heel incision devices market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Heel Incision Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Heel Incision Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Heel Incision Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Heel Incision Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Heel Incision Devices Market Size & Forecast, 2020-2028
4.5.1 Heel Incision Devices Market Size and Y-o-Y Growth
4.5.2 Heel Incision Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Micro-preemie
5.2.2 Preemie
5.2.3 Newborn
5.2.4 Infant
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Heel Incision Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Heel Incision Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Micro-preemie
9.6.2 Preemie
9.6.3 Newborn
9.6.4 Infant
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Micro-preemie
10.6.2 Preemie
10.6.3 Newborn
10.6.4 Infant
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Micro-preemie
11.6.2 Preemie
11.6.3 Newborn
11.6.4 Infant
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Micro-preemie
12.6.2 Preemie
12.6.3 Newborn
12.6.4 Infant
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Micro-preemie
13.6.2 Preemie
13.6.3 Newborn
13.6.4 Infant
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Heel Incision Devices Market: Competitive Dashboard
14.2 Global Heel Incision Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Owen Mumford Ltd.
14.3.2 Cardinal Health
14.3.3 NSP Medicals
14.3.4 Torvan Medical Inc
14.3.5 Smiths Medical
14.3.6 Clinical Innovations
14.3.7 LLC
14.3.8 MediCore
14.3.9 Vitrex Medical A/S
